This study evaluates a structured protocol for ultrasound-guided acupotomy combined with extracorporeal shock wave therapy for nonspecific low back pain, focusing on pain relief and improvement in lumbar function.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Research Article
This study evaluates a structured protocol for ultrasound-guided acupotomy combined with extracorporeal shock wave therapy for nonspecific low back pain, focusing on pain relief and improvement in lumbar function.
Nonspecific low back pain (NLBP) is a prevalent condition associated with pain and functional limitation. This study evaluated the therapeutic efficacy and procedural feasibility of ultrasound-guided acupotomy combined with extracorporeal shock wave therapy (ESWT) compared with monotherapy approaches for NLBP. A total of 90 patients with NLBP were randomly allocated to three groups (n = 30 each). In the acupotomy group, trigger points within the lumbar erector spinae muscles were identified by palpation and treated using acupotomy. In the shock wave group, ESWT was applied to painful areas using an energy density of 0.10–0.20 mJ/mm2 at a frequency of 10 Hz. In the combined group, ESWT and acupotomy were performed sequentially under ultrasound guidance. Clinical outcomes were evaluated using the visual analog scale (VAS), Oswestry Disability Index (ODI), and Japanese Orthopaedic Association (JOA) scores before treatment and at a 2-month follow-up. Therapeutic efficacy was additionally assessed in accordance with the Traditional Chinese Medicine Syndrome Diagnosis and Efficacy Standard. Baseline scores were comparable among groups (p > 0.05). After treatment, the combined group demonstrated significantly lower VAS and ODI scores, higher JOA scores, and a higher overall effective rate (93.33%) compared with the monotherapy groups (p < 0.05). This study presents a structured protocol for combining ultrasound-guided acupotomy with ESWT for NLBP and demonstrates improved short-term clinical outcomes compared with monotherapy.
Nonspecific low back pain (NLBP) is a general term used to describe a type of low back pain in which no clear pathological or anatomical changes can be identified upon diagnosis, and for which there is no definitive clinical cause or objective test findings. If symptoms have persisted for three months or longer, the condition is diagnosed as chronic nonspecific low back pain1. Although most patients with NLBP present with acute and self-limited symptoms, NLBP is often persistent and difficult to treat because of its multifactorial causes2. Approximately 7.3% of the global population is affected by NLBP, and nearly 500 million people take time off work each year due to NLBP, creating a substantial socioeconomic burden3. The incidence of NLBP is closely associated with age, with prevalence increasing significantly after 30 years of age and peaking between 41 and 55 years4. In China, the prevalence of NLBP has increased annually and has shown a trend toward younger patient populations.
Current rehabilitation strategies for NLBP include pharmacological, psychological, and physical therapies5. Extracorporeal shock wave therapy (ESWT) is an established non-invasive treatment modality for chronic musculoskeletal pain conditions, including NLBP6. Clinical studies have shown that ESWT can increase blood flow in the lumbopelvic region, reduce levels of inflammatory cytokines (such as TNF-α and IL-1β), and improve pain and functional scores7,8,9. ESWT delivers high-energy acoustic waves to targeted tissues and has been associated with pain relief and functional improvement in patients with chronic low back pain6,7,8,9.
Acupotomy is a minimally invasive intervention derived from traditional acupuncture techniques combined with modern soft tissue release methods10. Acupotomy has been used in the treatment of various chronic pain conditions, including NLBP, neck pain, shoulder pain, chronic headache or migraine, and osteoarthritis11,12. Conventional acupotomy is commonly performed using palpation-guided localization based on areas of tenderness or muscle tightness. However, blind localization may increase procedural variability and the risk of injury to surrounding structures13. Ultrasound can distinguish the fine structures and echogenic changes in subcutaneous tissues, precisely locate muscles, and provide real-time, dynamic observation of muscle changes during movement. Existing clinical evidence indicates14 that ultrasound‑guided acupotomy is superior to traditional manual palpation in improving pain symptoms and enhancing lumbar spine function. Ultrasound guidance enables precise identification of deep myofascial trigger points and real‑time avoidance of blood vessels and nerves, thereby enhancing treatment safety.
The combination of ultrasound-guided acupotomy and ESWT may provide complementary therapeutic effects for patients with NLBP11,13. Although both interventions have been applied individually in the management of NLBP, standardized procedural descriptions for their combined use under ultrasound guidance remain limited6,12. Therefore, this study enrolled patients with NLBP admitted to our hospital between January 2025 and November 2025 to evaluate the therapeutic efficacy of ultrasound-guided acupotomy combined with ESWT. In addition, this study presents a structured protocol describing treatment sequencing, ultrasound-guided needle insertion, and procedural monitoring during combined therapy.
Access restricted. Please log in or start a trial to view this content.
This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Qiqihar Medical University (No. [2024]92). Written informed consent was obtained from all participants. The research tools used in this protocol are listed in the Table of Materials.
1. Study participants
A total of 90 patients with NLBP admitted to the Second Affiliated Hospital of Qiqihar Medical University between January 2025 and November 2025 were enrolled in this randomized controlled trial and allocated to three groups (n = 30 each): the acupotomy group, the shock wave group, and the combined group (ultrasound-guided acupotomy plus ESWT).
Eligible participants were adults aged 18–60 years with a diagnosis of NLBP based on the 2016 Chinese Expert Consensus on the Diagnosis and Treatment of Acute/Chronic Nonspecific Low Back Pain16 and the 2017 American College of Physicians guideline for low back pain17, a pain duration of at least 3 months, and normal cognitive and communication abilities sufficient to cooperate with treatment and outcome evaluation.
Patients were excluded if they had specific spinal diseases (including infection, tumor, fracture, lumbar disc herniation, ankylosing spondylitis, or spina bifida occulta), severe osteoporosis, severe systemic disease, a history of psychiatric illness, a bleeding tendency or current anticoagulant use, pregnancy or lactation, or a body mass index (BMI) ≥28 kg/m2.
Participants were randomly allocated using a computer-generated randomization sequence. Allocation concealment was performed using sealed opaque envelopes prepared by an independent researcher who was not involved in recruitment or treatment. Due to the nature of the interventions, participant blinding was not feasible, particularly in the acupotomy and combined groups.
2. Treatment methods
All participants received functional and activities-of-daily-living training during the study period. Clinical assessments were performed within 24 h before treatment initiation and after 2 months of treatment using the visual analog scale (VAS), Japanese Orthopaedic Association (JOA) score, and Oswestry Disability Index (ODI). The study workflow and treatment sequence are shown in Supplementary Figure 1.
3. Observation indicators
Baseline demographic and clinical characteristics, including age, sex, disease duration, education level, and BMI, were recorded. Clinical outcomes were evaluated using the following scales:
VAS: 0–10 points, where 0 indicates no pain, and 10 indicates maximal pain;
ODI: a 10-item questionnaire assessing lumbar dysfunction, with higher scores indicating greater disability;
JOA: a comprehensive assessment of symptoms, signs, and daily functional limitation in patients with NLBP, with lower scores indicating greater dysfunction.
All scales were assessed before treatment and after 2 months of treatment.
Therapeutic efficacy was evaluated according to the State Administration of Traditional Chinese Medicine Syndrome Diagnosis and Efficacy Standard17. Outcomes were categorized as invalid, improvement, significant effect, or cure. The effective rate was defined as the sum of improvement, significant effect, and cure. Adverse events were monitored throughout the treatment and follow-up periods. Recorded adverse events included local bleeding, hematoma, infection, skin irritation, nerve palsy, and muscle spasm. Participants were evaluated during each treatment session and instructed to report delayed symptoms during follow-up assessments.
4. Statistical methods
Sample size estimation was performed using software based on an expected medium effect size (Cohen’s f = 0.25), a statistical power of 0.80, and a two-sided significance level (α) of 0.05. The minimum required sample size for three-group comparisons was calculated as 42 participants (14 per group). Considering an anticipated dropout rate of approximately 10%, at least 46–48 participants were required. A total of 90 participants (30 per group) were ultimately enrolled.
All statistical analyses were performed using SPSS software. Normality of continuous variables was assessed using the Shapiro–Wilk test. Normally distributed data are presented as mean ± standard deviation (SD) and were analyzed using one-way analysis of variance (ANOVA), followed by Tukey’s honestly significant difference (HSD) post hoc test. Non-normally distributed data are presented as median (interquartile range) and were analyzed using the Kruskal–Wallis test followed by Dunn’s test with Bonferroni correction. Within-group comparisons before and after treatment were analyzed using the paired t-test or the Wilcoxon signed-rank test as appropriate. Categorical variables are presented as counts and percentages and were analyzed using the chi-squared (χ2) test or Fisher’s exact test. A two-sided p-value < 0.05 was considered statistically significant.
Access restricted. Please log in or start a trial to view this content.
A total of 90 patients were enrolled in this study and randomly allocated to three groups, with 30 participants in each group. The flowchart of patient enrolment and allocation is shown in Figure 1.
In the acupotomy group, there were 18 men and 12 women, with a mean age of 47.73 ± 8.68 years. In the shock wave group, there were 16 men and 14 women, with a mean age of 47.70 ± 10.51 years. In the combined group, there were 15 men and 15 women, with a mean age of 47....
Access restricted. Please log in or start a trial to view this content.
Nonspecific low back pain (NLBP) is a common musculoskeletal condition characterized by pain and functional limitation without clear nerve root involvement or identifiable spinal pathology18. This study evaluated the therapeutic efficacy and procedural feasibility of ultrasound-guided acupotomy combined with extracorporeal shock wave therapy (ESWT) for patients with NLBP. The results demonstrated that the combined treatment group showed greater improvements in pain and lumbar function scores after...
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing interests.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Acupotomy needle | Jiangsu Huayou Medical Devices Co., Ltd., Suqian, China | 0.40 mm × 50 mm | Used for soft tissue release during acupotomy. |
| Extracorporeal shock wave therapy device | Zimmer MedizinSysteme GmbH, Tuttlingen, Germany | enPuls Version 2.0 | Used to deliver extracorporeal shock wave therapy (ESWT). |
| G*Power software | Heinrich Heine University Düsseldorf, Düsseldorf, Germany | NA | Used for a priori sample size estimation and statistical power analysis. |
| Portable color Doppler ultrasound system | Shenzhen Huasheng Medical Technology Co., Ltd., Shenzhen, China | Clover 60 | Used for ultrasound guidance during acupotomy and treatment-site visualization. |
| SPSS Statistics | IBM Corp., Armonk, NY, USA | SPSS Statistics Version 26.0 | Used for statistical analysis of study data. |
Access restricted. Please log in or start a trial to view this content.